Exposure to Candesartan During the First Trimester of Pregnancy in Type 1 Diabetes: Experience From the Placebo-Controlled Diabetic Retinopathy Candesartan Trials

Diabetologia - Germany
doi 10.1007/s00125-010-2040-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Risk Indicators Predictive for Severe Hypoglycemia During the First Trimester of Type 1 Diabetic Pregnancy

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2002English

Candesartan Targeting of Angiotensin II Type 1 Receptor Demonstrates Benefits for Hypertension in Pregnancy via the NF‑κB Signaling Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Diabetic Retinopathy in Type 1 Diabetes Patients in Western Norway

Acta Ophthalmologica
MedicineOphthalmology
2018English

Cost Effectiveness Analysis of Candesartan Therapy in Comparison to Candesartan-Amlodipine Therapy on Hypertensive Outpatients

Open Access Macedonian Journal of Medical Sciences
Medicine
2019English

Retinal Neurodegeneration Exists in Type 1 Diabetes Prior Diabetic Retinopathy

Acta Ophthalmologica
MedicineOphthalmology
2018English

Prevalence of Diabetic Retinopathy in Patients With Type 1 Diabetes Mellitus

Revista da Associacao Medica Brasileira
Medicine
2009English

Diabetic Retinopathy in African Americans With Type 1 Diabetes: The New Jersey 725

Archives of Ophthalmology
2000English

Candesartan Kan Forebygge Migrene

Tidsskrift for den Norske Laegeforening
Medicine
2014English

Biorelevant Dissolution of Candesartan Cilexetil

ADMET and DMPK
PharmacologyHealthMedicineToxicologyChemistryPharmaceutics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy